Technology

June 5, 2015.

FDA cites 17 observations including air handling, quality control, and deficient microbial monitoring at NIH’s Clinical Center Pharmaceutical Development Section.

June 4, 2015.

June 4, 2015.

June 2, 2015.

June 2, 2015.

June 2, 2015.

Bryan Spielman outlines why China is poised for a data renaissance-one that could play a pivotal role in the next wave of pharma innovation.

June 1, 2015.

May 31, 2015.

June 1, 2015.

The World Medical Innovation Forum unveils its inaugural list of breakthrough neuroscience technologies. We highlight a few here.

May 29, 2015.

May 29, 2015.

Prescription drug usage data on more than one million Marketplace enrollees suggest that costs for specialty drugs were 36% higher for people with Obamacare.

Boehringer Ingelheim announces FDA approval of Stiolto Respimat inhaler for the treatment of COPD.

MIT scientist Robert Langer will speak at BIO 2015 on a panel about venture capitalism in biotechnology.

Compliance with the new traceability requirements necessitates an understanding of how and when to begin implementing changes in an ever-evolving industry.

May 26, 2015.

Medicines considered critically important for patients to remain available.

The former New England Compounding Center will pay $200 million to victims and creditors for the 2012 outbreak of meningitis that killed 64.

Physician confidence in biosimilars and extrapolation of indications are two of the most important factors governing the acceptance and sustainability of biosimilars, say industry panelists.

The House Energy and Commerce Committee gave unanimous approval to the landmark 21st Century Cures Act reform bill on May 21, 2015.

May 20, 2015.

Pharm Exec talks to Matt Wallach, President of Veeva Systems, an upstart start-up whose mix of cutting-edge technology and strong customer orientation has brought it to the top rank in providing cloud-based data management services to the industry.

May 20, 2015.

Alexion will construct a biologics facility in Ireland that is its first outside the US.

The company picked up the Pharm Exec Brand of the Year award last week at the iPharma event in New York.

May 19, 2015.

Raplixa fibrin sealant, the first approved spray-dried biologic, is a hemostatic agent that helps control bleeding from small blood vessels during surgery.